产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 询价 | |||
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 | |||
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 询价 | |||
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 | |||
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 |
CAS No. |
954126-98-8 |
|---|---|
中文名称 |
(S)-1-(4-氯-2-羟基-3-(哌啶-3-基磺酰基)苯基)-3-(3-氟-2-甲基苯基)脲 |
英文名称 |
Danirixin |
别名 |
AKOS030527036 | SCHEMBL1198688 | GTPL8500 | HY-B1568 | UNII-R318PGH5VP | SPBio_002358 | MLS003899212 | EX-A1178 | GSK1325756B | GSK-1325756B | HY-19768 | AC-36168 | KBio1_000455 | GSK 1325756 | GSK1325756 | GSK-1325756 | DANIRIXIN [INN] | D10387 | Danirix |
标准英文名 |
(S)-1-(4-chloro-2-hydroxy-3-(piperidin-3-ylsulfonyl)phenyl)-3-(3-fluoro-2-methylphenyl)urea |
MDL No. |
MFCD27987922 |
分子式 |
C19H21ClFN3O4S |
分子量 |
441.91 |
精确分子量 |
441.09 |
SMILES |
O=C(NC1=CC=C(Cl)C(S([C@H]2CCCNC2)(=O)=O)=C1O)NC3=C(C)C(F)=CC=C3 |
标准SMILES |
CC1C(F)=CC=CC=1NC(=O)NC1=CC=C(Cl)C(=C1O)S(=O)(=O)[C@@H]1CNCCC1 |
性状 |
White to off-white powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
NGYNBSHYFOFVLS-LBPRGKRZSA-N |
危险类别(旧) |
H302 |
存储要求 |
Keep in dark place, Sealed in dry, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral(Category 4) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|